Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Clostridioides Difficile Infection Interventions: Drug: AZD5148; Other: Placebo Sponsors: AstraZeneca Recruiting Conditions: Clostridioides Difficile Infection Interventions: Drug: AZD5148; Other: Placebo Sponsors: AstraZeneca...

Precision Detection and Prediction of Atrial Arrhythmias Using Artificial Intelligence and Consumer Wearable Devices

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Atrial Fibrillation (AF) Sponsors: Royal Brompton & Harefield NHS Foundation Trust Not yet recruiting Conditions: Atrial Fibrillation (AF) Sponsors: Royal Brompton & Harefield NHS Foundation Trust Not yet...

Effects of VOJTA Technique on Ataxic Cerebral Palsy.

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Ataxic Cerebral Palsy Interventions: Behavioral: VOJTA; Behavioral: Conventional Physical Therapy Sponsors: Lahore University of Biological and Applied Sciences Not yet recruiting Conditions: Ataxic Cerebral Palsy Interventions: Behavioral: VOJTA;...

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Plaque Psoriasis Interventions: Drug: ORKA-001; Other: Placebo Sponsors: Oruka Therapeutics, Inc. Recruiting Conditions: Plaque Psoriasis Interventions: Drug: ORKA-001; Other: Placebo Sponsors: Oruka Therapeutics, Inc....

Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Influenza Interventions: Biological: Recombinant Influenza vaccine candidate; Biological: Commercial Influenza vaccine Sponsors: Aramis Biotechnologies Inc. Not yet recruiting Conditions: Influenza Interventions: Biological: Recombinant Influenza vaccine...

Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome in the European Union (LEAP-EU)

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Alagille Syndrome Interventions: Drug: Livmarli Oral Product Sponsors: Mirum Pharmaceuticals, Inc. Recruiting Conditions: Alagille Syndrome Interventions: Drug: Livmarli Oral Product Sponsors: Mirum Pharmaceuticals, Inc....